These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


115 related items for PubMed ID: 14464901

  • 1. Combined tranlcypromine and trifluoperazine therapy in general medicine.
    LEWIS RA.
    Can Psychiatr Assoc J; 1962; 7(Suppl)():74-6. PubMed ID: 14464901
    [No Abstract] [Full Text] [Related]

  • 2. Combined tranylcypromine-trifluoperazine therapy in obstetrics and gynaecology.
    PRUETER GW.
    Can Psychiatr Assoc J; 1962; 7(Suppl)():77-83. PubMed ID: 14489022
    [No Abstract] [Full Text] [Related]

  • 3. The use of tranylcypromine and trifluoperazine in the management of coexisting depression and anxiety.
    GODDARD ES.
    Can Psychiatr Assoc J; 1962; 7(Suppl)():87-90. PubMed ID: 13899397
    [No Abstract] [Full Text] [Related]

  • 4. The relative merits of tranylcypromine alone and tranylcypromine in combination with trifluoperazine in the treatment of patients with severe agitated depressions.
    LESSE S.
    Am J Psychiatry; 1962 Apr; 118():934-5. PubMed ID: 14464348
    [No Abstract] [Full Text] [Related]

  • 5. The effect of tranylcypromine-trifluoperazine in the treatment of depressive states.
    BRAM G.
    Can Psychiatr Assoc J; 1962 Apr; 7(Suppl)():84-6. PubMed ID: 13872435
    [No Abstract] [Full Text] [Related]

  • 6. Parstelin in anxiety states and depression.
    HEMPHILL RE, FOSTER AR.
    J Coll Gen Pract; 1962 May; 5(2):238-45. PubMed ID: 13906375
    [No Abstract] [Full Text] [Related]

  • 7. Neuropharmacology of tranylcypromine and trifluoperazine.
    TEDESCHI RE, TEDESCHI DH, FELLOWS EJ.
    Can Psychiatr Assoc J; 1962 May; 7(Suppl)():55-9. PubMed ID: 13920073
    [No Abstract] [Full Text] [Related]

  • 8. Some effects of tranylcypromine and trifluoperazine on electrocortical activity (EEG activation).
    LING GM.
    Can Psychiatr Assoc J; 1962 May; 7(Suppl)():44-54. PubMed ID: 14465574
    [No Abstract] [Full Text] [Related]

  • 9. The unique therapeutic properties of tranylcypromine and trifluoperazine (parstelin).
    SCHIELE BC.
    Am J Psychiatry; 1960 Sep; 117():245-6. PubMed ID: 13747600
    [No Abstract] [Full Text] [Related]

  • 10. Combined use of tranylcypromine and trifluoperazine in ambulatory treatment of patients with agitated depressions: Preliminary evaluation.
    LESSE S.
    N Y State J Med; 1961 Jun 01; 61():1898-903. PubMed ID: 13761180
    [No Abstract] [Full Text] [Related]

  • 11. Trifluoperazine and Tranylcypromine in chronic refractory schizophrenics.
    KRUSE W.
    Am J Psychiatry; 1960 Dec 01; 117():548-9. PubMed ID: 13754637
    [No Abstract] [Full Text] [Related]

  • 12. The use of stelazine and parnate in chronic, withdrawn patients.
    VOGT AH.
    Am J Psychiatry; 1961 Sep 01; 118():256-7. PubMed ID: 13781857
    [No Abstract] [Full Text] [Related]

  • 13. Clinical study of a potent antidepressant: tranylcypromine with trifluoperazine in the aged chronically ill.
    STRAKER M, GRAUER H.
    Can Psychiatr Assoc J; 1962 Sep 01; 7(Supl)():96-103. PubMed ID: 13917604
    [No Abstract] [Full Text] [Related]

  • 14. The prediction of response to tranylcypromine plus trifluoperazine by the MMPI.
    SULZER ES, SCHIELE BC.
    Am J Psychiatry; 1962 Jul 01; 119():69-70. PubMed ID: 13918361
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of anxiety states by antidepressant drugs.
    SARGANT W, DALLY P.
    Br Med J; 1962 Jan 06; 1(5270):6-9. PubMed ID: 14497198
    [No Abstract] [Full Text] [Related]

  • 16. Tranylcypromine and the extrapyramidal syndromes.
    BARBEAU A, DUCHASTEL Y.
    Can Psychiatr Assoc J; 1962 Jan 06; 7(Suppl)():91-5. PubMed ID: 13864822
    [No Abstract] [Full Text] [Related]

  • 17. A clinical trial of an antidepressant, tranylcy-promine ("Parnate").
    KINGSTON WR.
    Med J Aust; 1962 Jun 30; 49(1)():1011-2. PubMed ID: 14456153
    [No Abstract] [Full Text] [Related]

  • 18. Tranylcypromine on fifty ambulatory psychiatric patients.
    DARLING HF.
    Dis Nerv Syst; 1962 Feb 30; 23():91-2. PubMed ID: 13883578
    [No Abstract] [Full Text] [Related]

  • 19. Experiences with N, N-dimethyl-2-phenylcyclo-propylamine in chronic anergic schizophrenic patients.
    KURLAND AA, McCUSKER K.
    J Neuropsychiatr; 1962 Feb 30; 3():190-4. PubMed ID: 14460738
    [No Abstract] [Full Text] [Related]

  • 20. DEPRESSIONS... THEIR MANAGEMENT AND TREATMENT.
    WALLING RG.
    J Ark Med Soc; 1964 Mar 30; 60():361-3. PubMed ID: 14127558
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.